Selected research
Market Analysis & Forecast
Global General Anesthetic for Surgery Market Analysis and Forecast 2026-2032
Market perspective
The global General Anesthetic for Surgery market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for General Anesthetic for Surgery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for General Anesthetic for Surgery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for General Anesthetic for Surgery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for General Anesthetic for Surgery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of General Anesthetic for Surgery include Yichang Humanwell, Xi'an Libang, Nhwa, Hengrui, Fresenius-Kabi, B.Braun, Baxter Healthcare, AbbVie and Piramal, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for General Anesthetic for Surgery, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of General Anesthetic for Surgery, also provides the sales of main regions and countries. Of the upcoming market potential for General Anesthetic for Surgery, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the General Anesthetic for Surgery sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global General Anesthetic for Surgery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for General Anesthetic for Surgery sales, projected growth trends, production technology, application and end-user industry.
General Anesthetic for Surgery Segment by Company
Yichang Humanwell
Xi'an Libang
Nhwa
Hengrui
Fresenius-Kabi
B.Braun
Baxter Healthcare
AbbVie
Piramal
Maruishi
Hikma Pharmaceuticals
Aspen Pharma
General Anesthetic for Surgery Segment by Type
Isoflurane
Etomidate
Remifentanil
Sevoflurane
Propofol
Other
General Anesthetic for Surgery Segment by Application
Intravenous Anesthetics
Inhalational Anesthetics
General Anesthetic for Surgery Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Anesthetic for Surgery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of General Anesthetic for Surgery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Anesthetic for Surgery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of General Anesthetic for Surgery in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of General Anesthetic for Surgery manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, General Anesthetic for Surgery sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Isoflurane
- Etomidate
- Remifentanil
- Sevoflurane
- Propofol
- Other
Applications
- Intravenous Anesthetics
- Inhalational Anesthetics
Companies covered
- Yichang Humanwell
- Xi'an Libang
- Nhwa
- Hengrui
- Fresenius-Kabi
- B.Braun
- Baxter Healthcare
- AbbVie
- Piramal
- Maruishi
- Hikma Pharmaceuticals
- Aspen Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 General Anesthetic for Surgery Market by Type
- 1.2.1 Global General Anesthetic for Surgery Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Isoflurane
- 1.2.3 Etomidate
- 1.2.4 Remifentanil
- 1.2.5 Sevoflurane
- 1.2.6 Propofol
- 1.2.7 Other
- 1.3 General Anesthetic for Surgery Market by Application
- 1.3.1 Global General Anesthetic for Surgery Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Intravenous Anesthetics
- 1.3.3 Inhalational Anesthetics
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 General Anesthetic for Surgery Market Dynamics
- 2.1 General Anesthetic for Surgery Industry Trends
- 2.2 General Anesthetic for Surgery Industry Drivers
- 2.3 General Anesthetic for Surgery Industry Opportunities and Challenges
- 2.4 General Anesthetic for Surgery Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global General Anesthetic for Surgery Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global General Anesthetic for Surgery Revenue by Region
- 3.2.1 Global General Anesthetic for Surgery Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global General Anesthetic for Surgery Revenue by Region (2021-2026)
- 3.2.3 Global General Anesthetic for Surgery Revenue by Region (2027-2032)
- 3.2.4 Global General Anesthetic for Surgery Revenue Market Share by Region (2021-2032)
- 3.3 Global General Anesthetic for Surgery Sales Estimates and Forecasts 2021-2032
- 3.4 Global General Anesthetic for Surgery Sales by Region
- 3.4.1 Global General Anesthetic for Surgery Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global General Anesthetic for Surgery Sales by Region (2021-2026)
- 3.4.3 Global General Anesthetic for Surgery Sales by Region (2027-2032)
- 3.4.4 Global General Anesthetic for Surgery Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global General Anesthetic for Surgery Revenue by Manufacturers
- 4.1.1 Global General Anesthetic for Surgery Revenue by Manufacturers (2021-2026)
- 4.1.2 Global General Anesthetic for Surgery Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global General Anesthetic for Surgery Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global General Anesthetic for Surgery Sales by Manufacturers
- 4.2.1 Global General Anesthetic for Surgery Sales by Manufacturers (2021-2026)
- 4.2.2 Global General Anesthetic for Surgery Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global General Anesthetic for Surgery Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global General Anesthetic for Surgery Sales Price by Manufacturers (2021-2026)
- 4.4 Global General Anesthetic for Surgery Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global General Anesthetic for Surgery Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global General Anesthetic for Surgery Manufacturers, Product Type & Application
- 4.7 Global General Anesthetic for Surgery Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global General Anesthetic for Surgery Market CR5 and HHI
- 4.8.2 2025 General Anesthetic for Surgery Tier 1, Tier 2, and Tier 3
5 General Anesthetic for Surgery Market by Type
- 5.1 Global General Anesthetic for Surgery Revenue by Type
- 5.1.1 Global General Anesthetic for Surgery Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global General Anesthetic for Surgery Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global General Anesthetic for Surgery Revenue Market Share by Type (2021-2032)
- 5.2 Global General Anesthetic for Surgery Sales by Type
- 5.2.1 Global General Anesthetic for Surgery Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global General Anesthetic for Surgery Sales by Type (2021-2032) & (k units)
- 5.2.3 Global General Anesthetic for Surgery Sales Market Share by Type (2021-2032)
- 5.3 Global General Anesthetic for Surgery Price by Type
6 General Anesthetic for Surgery Market by Application
- 6.1 Global General Anesthetic for Surgery Revenue by Application
- 6.1.1 Global General Anesthetic for Surgery Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global General Anesthetic for Surgery Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global General Anesthetic for Surgery Revenue Market Share by Application (2021-2032)
- 6.2 Global General Anesthetic for Surgery Sales by Application
- 6.2.1 Global General Anesthetic for Surgery Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global General Anesthetic for Surgery Sales by Application (2021-2032) & (k units)
- 6.2.3 Global General Anesthetic for Surgery Sales Market Share by Application (2021-2032)
- 6.3 Global General Anesthetic for Surgery Price by Application
7 Company Profiles
- 7.1 Yichang Humanwell
- 7.1.1 Yichang Humanwell Company Information
- 7.1.2 Yichang Humanwell Business Overview
- 7.1.3 Yichang Humanwell General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Yichang Humanwell General Anesthetic for Surgery Product Portfolio
- 7.1.5 Yichang Humanwell Recent Developments
- 7.2 Xi'an Libang
- 7.2.1 Xi'an Libang Company Information
- 7.2.2 Xi'an Libang Business Overview
- 7.2.3 Xi'an Libang General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Xi'an Libang General Anesthetic for Surgery Product Portfolio
- 7.2.5 Xi'an Libang Recent Developments
- 7.3 Nhwa
- 7.3.1 Nhwa Company Information
- 7.3.2 Nhwa Business Overview
- 7.3.3 Nhwa General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Nhwa General Anesthetic for Surgery Product Portfolio
- 7.3.5 Nhwa Recent Developments
- 7.4 Hengrui
- 7.4.1 Hengrui Company Information
- 7.4.2 Hengrui Business Overview
- 7.4.3 Hengrui General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Hengrui General Anesthetic for Surgery Product Portfolio
- 7.4.5 Hengrui Recent Developments
- 7.5 Fresenius-Kabi
- 7.5.1 Fresenius-Kabi Company Information
- 7.5.2 Fresenius-Kabi Business Overview
- 7.5.3 Fresenius-Kabi General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Fresenius-Kabi General Anesthetic for Surgery Product Portfolio
- 7.5.5 Fresenius-Kabi Recent Developments
- 7.6 B.Braun
- 7.6.1 B.Braun Company Information
- 7.6.2 B.Braun Business Overview
- 7.6.3 B.Braun General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 B.Braun General Anesthetic for Surgery Product Portfolio
- 7.6.5 B.Braun Recent Developments
- 7.7 Baxter Healthcare
- 7.7.1 Baxter Healthcare Company Information
- 7.7.2 Baxter Healthcare Business Overview
- 7.7.3 Baxter Healthcare General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Baxter Healthcare General Anesthetic for Surgery Product Portfolio
- 7.7.5 Baxter Healthcare Recent Developments
- 7.8 AbbVie
- 7.8.1 AbbVie Company Information
- 7.8.2 AbbVie Business Overview
- 7.8.3 AbbVie General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 AbbVie General Anesthetic for Surgery Product Portfolio
- 7.8.5 AbbVie Recent Developments
- 7.9 Piramal
- 7.9.1 Piramal Company Information
- 7.9.2 Piramal Business Overview
- 7.9.3 Piramal General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Piramal General Anesthetic for Surgery Product Portfolio
- 7.9.5 Piramal Recent Developments
- 7.10 Maruishi
- 7.10.1 Maruishi Company Information
- 7.10.2 Maruishi Business Overview
- 7.10.3 Maruishi General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Maruishi General Anesthetic for Surgery Product Portfolio
- 7.10.5 Maruishi Recent Developments
- 7.11 Hikma Pharmaceuticals
- 7.11.1 Hikma Pharmaceuticals Company Information
- 7.11.2 Hikma Pharmaceuticals Business Overview
- 7.11.3 Hikma Pharmaceuticals General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Hikma Pharmaceuticals General Anesthetic for Surgery Product Portfolio
- 7.11.5 Hikma Pharmaceuticals Recent Developments
- 7.12 Aspen Pharma
- 7.12.1 Aspen Pharma Company Information
- 7.12.2 Aspen Pharma Business Overview
- 7.12.3 Aspen Pharma General Anesthetic for Surgery Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Aspen Pharma General Anesthetic for Surgery Product Portfolio
- 7.12.5 Aspen Pharma Recent Developments
8 North America
- 8.1 North America General Anesthetic for Surgery Market Size by Type
- 8.1.1 North America General Anesthetic for Surgery Revenue by Type (2021-2032)
- 8.1.2 North America General Anesthetic for Surgery Sales by Type (2021-2032)
- 8.1.3 North America General Anesthetic for Surgery Price by Type (2021-2032)
- 8.2 North America General Anesthetic for Surgery Market Size by Application
- 8.2.1 North America General Anesthetic for Surgery Revenue by Application (2021-2032)
- 8.2.2 North America General Anesthetic for Surgery Sales by Application (2021-2032)
- 8.2.3 North America General Anesthetic for Surgery Price by Application (2021-2032)
- 8.3 North America General Anesthetic for Surgery Market Size by Country
- 8.3.1 North America General Anesthetic for Surgery Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America General Anesthetic for Surgery Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America General Anesthetic for Surgery Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe General Anesthetic for Surgery Market Size by Type
- 9.1.1 Europe General Anesthetic for Surgery Revenue by Type (2021-2032)
- 9.1.2 Europe General Anesthetic for Surgery Sales by Type (2021-2032)
- 9.1.3 Europe General Anesthetic for Surgery Price by Type (2021-2032)
- 9.2 Europe General Anesthetic for Surgery Market Size by Application
- 9.2.1 Europe General Anesthetic for Surgery Revenue by Application (2021-2032)
- 9.2.2 Europe General Anesthetic for Surgery Sales by Application (2021-2032)
- 9.2.3 Europe General Anesthetic for Surgery Price by Application (2021-2032)
- 9.3 Europe General Anesthetic for Surgery Market Size by Country
- 9.3.1 Europe General Anesthetic for Surgery Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe General Anesthetic for Surgery Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe General Anesthetic for Surgery Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China General Anesthetic for Surgery Market Size by Type
- 10.1.1 China General Anesthetic for Surgery Revenue by Type (2021-2032)
- 10.1.2 China General Anesthetic for Surgery Sales by Type (2021-2032)
- 10.1.3 China General Anesthetic for Surgery Price by Type (2021-2032)
- 10.2 China General Anesthetic for Surgery Market Size by Application
- 10.2.1 China General Anesthetic for Surgery Revenue by Application (2021-2032)
- 10.2.2 China General Anesthetic for Surgery Sales by Application (2021-2032)
- 10.2.3 China General Anesthetic for Surgery Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia General Anesthetic for Surgery Market Size by Type
- 11.1.1 Asia General Anesthetic for Surgery Revenue by Type (2021-2032)
- 11.1.2 Asia General Anesthetic for Surgery Sales by Type (2021-2032)
- 11.1.3 Asia General Anesthetic for Surgery Price by Type (2021-2032)
- 11.2 Asia General Anesthetic for Surgery Market Size by Application
- 11.2.1 Asia General Anesthetic for Surgery Revenue by Application (2021-2032)
- 11.2.2 Asia General Anesthetic for Surgery Sales by Application (2021-2032)
- 11.2.3 Asia General Anesthetic for Surgery Price by Application (2021-2032)
- 11.3 Asia General Anesthetic for Surgery Market Size by Country
- 11.3.1 Asia General Anesthetic for Surgery Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia General Anesthetic for Surgery Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia General Anesthetic for Surgery Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA General Anesthetic for Surgery Market Size by Type
- 12.1.1 SAMEA General Anesthetic for Surgery Revenue by Type (2021-2032)
- 12.1.2 SAMEA General Anesthetic for Surgery Sales by Type (2021-2032)
- 12.1.3 SAMEA General Anesthetic for Surgery Price by Type (2021-2032)
- 12.2 SAMEA General Anesthetic for Surgery Market Size by Application
- 12.2.1 SAMEA General Anesthetic for Surgery Revenue by Application (2021-2032)
- 12.2.2 SAMEA General Anesthetic for Surgery Sales by Application (2021-2032)
- 12.2.3 SAMEA General Anesthetic for Surgery Price by Application (2021-2032)
- 12.3 SAMEA General Anesthetic for Surgery Market Size by Country
- 12.3.1 SAMEA General Anesthetic for Surgery Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA General Anesthetic for Surgery Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA General Anesthetic for Surgery Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 General Anesthetic for Surgery Value Chain Analysis
- 13.1.1 General Anesthetic for Surgery Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 General Anesthetic for Surgery Production Mode & Process
- 13.2 General Anesthetic for Surgery Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 General Anesthetic for Surgery Distributors
- 13.2.3 General Anesthetic for Surgery Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst